DRIEHAUS CAPITAL MANAGEMENT LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$25,747,000
+11875.3%
805,861
+20552.5%
0.42%
+10325.0%
Q3 2020$215,000
-98.6%
3,902
-98.4%
0.00%
-98.9%
Q2 2020$15,094,000
-21.0%
239,098
-36.1%
0.37%
-42.5%
Q1 2020$19,102,000
-32.7%
373,884
+4.8%
0.64%
-15.4%
Q4 2019$28,371,000
+243.0%
356,910
+109.4%
0.75%
+180.3%
Q3 2019$8,271,000
-25.0%
170,459
-18.8%
0.27%
-22.3%
Q2 2019$11,035,000
+38.9%
209,797
+39.7%
0.35%
+16.1%
Q1 2019$7,947,000
+25.3%
150,142
-2.8%
0.30%
+10.0%
Q4 2018$6,343,000
-14.5%
154,522
-20.8%
0.27%
+18.9%
Q3 2018$7,418,000
-45.8%
195,216
-35.5%
0.23%
-50.6%
Q2 2018$13,674,000
-1.3%
302,529
+5.5%
0.46%
-5.5%
Q1 2018$13,856,000
+41.6%
286,871
+15.4%
0.49%
+31.8%
Q4 2017$9,784,000
+91.7%
248,629
+51.3%
0.37%
+86.4%
Q3 2017$5,103,000
+18.5%
164,354
+4.4%
0.20%
+25.9%
Q2 2017$4,307,000
-19.7%
157,461
+8.2%
0.16%
-14.1%
Q1 2017$5,365,000
-37.8%
145,582
-61.1%
0.18%
-36.8%
Q3 2016$8,623,000
+258.7%
374,108
+158.2%
0.29%
+238.4%
Q2 2016$2,404,000
+4.0%
144,912
-0.6%
0.09%
+14.7%
Q1 2016$2,312,000
-64.5%
145,794
-27.6%
0.08%
-65.8%
Q4 2015$6,507,000
-36.6%
201,262
-17.3%
0.22%
-40.8%
Q3 2015$10,262,000243,3990.37%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders